EGFR-mutation

OncoDaily

News Feed Opinion Career Insight Dialogues Blog Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

EGFR-mutation

Aug 26, 2024, 21:24 | Blog

Tanja Obradovic: Can we expect new EGFR TKI to surpass osimertinib in primary tumor and intracranial progression of NSCLC

Tanja Obradovic posted on LinkedIn: “Can we expect new EGFR TKI that can significantly surpass…

Jun 21, 2024, 13:43 | Insight

Luca Dezzani: We are requesting approval from the U.S. FDA EGFR-mutated NSCLC therapy

Luca Dezzani, Vice President of US Oncology Medical Affairs at Johnson & Johnson, shared a…

Jun 13, 2024, 10:46 | Blog

Amy C. Moore: LUNGevity Foundation International Lung Cancer Survivorship Conference

Amy C. Moore, VP of Global Engagement and Patient Partnerships, LUNGevity Foundation, shared a post…

Jun 10, 2024, 00:53 | Insight

Vijith Shetty: Osimertinib Could Alter SOC for Stage III EGFR+ NSCLC

Vijith Shetty, Associate Professor and Consultant Medical Oncologist at KS Hegde Medical Academy, shared on…

May 23, 2024, 07:56 | Blog

Chinmay Jani: Let's explore EGFR Exon 20 Insertion NSCLC with a twist of Miami flair!

Chinmay Jani, Clinical Fellow, Hematology & Oncology at University of Miami, made the following post…

Apr 26, 2024, 09:26 | Insight

Chul Kim: Thoughtful discussion and great talk by Rachel Sanborn about recent approval of FLAURA2

Chul Kim, Thoracic Medical Oncologist at Georgetown University, shared a post on X/Twitter: ''First-line treatment…

Dec 5, 2023, 19:09 | Blog

Narjust Florez: Ready for a Pregnancy and Lung Cancer Tweetorial?

Narjust Florez shared a post on her X/Twitter page: "Ready for a Pregnancy and Lung…

Nov 12, 2023, 17:56 | Drugs

David Planchard: Thank you to the patients who actively participated in this research

David Planchard, Professor at the University Paris Saclay, posted on X/Twitter. "Proud to lead this…

All: 8 Posts: 1 - 100